Go Pro
→ The end may be near for these iconic stocks (From Chaikin Analytics) (Ad)tc pixel Free ASND Stock Alerts

Ascendis Pharma A/S (ASND) Short Interest Ratio & Short Volume

Ascendis Pharma A/S logo
$247.91 -1.45 (-0.58%)
As of 08/28/2026 04:00 PM Eastern
Compare

Ascendis Pharma A/S Short Interest Overview

As of August 14, 2026, Ascendis Pharma A/S (ASND) had a short interest of 3.69 million shares sold short, representing 9.85% of the public float. This marks a 8.30% increase in short interest since the prior report. The short interest ratio (days to cover) is 6.3, meaning it would take 6.3 days of the average trading volume of 503,223 shares to cover all short positions.

Current Short Interest
3,687,311 shares
Previous Short Interest
3,404,687 shares
Change Vs. Previous Month
8.30%
Dollar Volume Sold Short
$916.30 million
Short Interest Ratio
6.3 Days to Cover
Last Record Date
August 14, 2026
Outstanding Shares
62,380,000 shares
Short Percent of Float
9.85%
Today's Trading Volume
314,792 shares
Average Trading Volume
503,223 shares
Today's Volume Vs. Average
63%
Short Selling Ascendis Pharma A/S?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Ascendis Pharma A/S and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

ASND Short Interest Over Time

ASND Days to Cover Over Time

ASND Percentage of Float Shorted Over Time

Ascendis Pharma A/S Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/14/20263,687,311 shares $916.30 million +8.3%9.9%6.25 $248.50
7/31/20263,404,687 shares $830.44 million +9.7%9.1%7.21 $243.91
7/15/20263,104,151 shares $833.68 million -5.3%8.3%5.61 $268.57
6/30/20263,277,898 shares $874.28 million +65.0%8.8%2.52 $266.72
6/15/20261,987,044 shares $443.69 million +15.5%5.3%3.45 $223.29
5/29/20261,720,143 shares $385.50 million -0.1%4.6%3.1 $224.11
5/15/20261,721,179 shares $413.94 million -39.2%4.6%2.76 $240.50
4/30/20262,832,689 shares $649.76 million -22.5%7.6%3.05 $229.38
4/15/20263,654,940 shares $883.44 million -1.1%9.8%5.55 $241.71
3/31/20263,695,502 shares $845.27 million -4.0%9.9%9.45 $228.73
3/13/20263,850,275 shares $870.09 million -0.6%10.4%5.02 $225.98
2/27/20263,871,638 shares $904.03 million +1.8%10.3%6.07 $233.50
2/13/20263,802,853 shares $822.63 million +31.3%10.2%4.48 $216.32
1/30/20262,896,919 shares $654.99 million -8.4%7.8%4.15 $226.10
1/15/20263,162,754 shares $680.12 million -8.4%8.5%4.82 $215.04
12/31/20253,453,178 shares $736.36 million +1.9%9.3%5.94 $213.24
12/15/20253,388,247 shares $722.51 million +2.8%9.1%3.99 $213.24
11/28/20253,296,433 shares $700.28 million +10.3%8.9%6.17 $212.44
11/14/20252,987,645 shares $610.67 million -15.8%8.1%4.75 $204.40
10/31/20253,549,505 shares $715.58 million +3.7%9.6%9.1 $201.60
10/15/20253,420,000 shares $708.35 million +33.6%9.2%7.3 $207.12
9/30/20252,560,000 shares $508.95 million +11.8%N/A5.5 $198.81
9/15/20252,290,000 shares $445.68 million -14.6%N/A5 $194.62
8/31/20252,680,000 shares $520.64 million +7.6%7.3%5.8 $194.27
8/15/20252,490,000 shares $493.82 million -9.8%N/A5.3 $198.32
7/31/20252,760,000 shares $478.86 million +1.1%7.5%5.9 $173.50
7/15/20252,730,000 shares $477.07 million +20.8%N/A5.8 $174.75
6/30/20252,260,000 shares $390.08 million -16.0%6.2%4.5 $172.60
6/15/20252,690,000 shares $459.45 million -20.4%7.3%5.4 $170.80
5/31/20253,380,000 shares $552.22 million -10.1%9.3%6.7 $163.38
5/15/20253,760,000 shares $592.35 million -3.6%10.3%7.5 $157.54
4/30/20253,900,000 shares $664.72 million -5.8%N/A7.1 $170.44
4/15/20254,140,000 shares $637.23 million -3.9%11.4%8 $153.92
3/31/20254,310,000 shares $671.76 million -1.6%11.8%8.5 $155.86
3/15/20254,380,000 shares $670.05 million +10.1%12.0%9.6 $152.98
2/28/20253,980,000 shares $623.19 million +9.6%10.9%8.7 $156.58
2/15/20253,630,000 shares $523.01 million +10.3%10.0%8 $144.08
1/31/20253,290,000 shares $429.87 million +1.2%N/A7.4 $130.66
1/15/20253,250,000 shares $438.33 million -5.0%N/A7.5 $134.87
12/31/20243,420,000 shares $470.83 million -5.5%N/A8 $137.67
The REAL Reason Trump is Invading Iran (Ad)

For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel

Click here to find out what it is.
12/15/20243,620,000 shares $470.13 million -4.0%N/A8.2 $129.87
11/30/20243,770,000 shares $513.02 million +5.6%N/A6.4 $136.08
11/15/20243,570,000 shares $451.64 million +4.7%N/A5.6 $126.51
10/31/20243,410,000 shares $418.82 million +5.6%N/A5.4 $122.82
10/15/20243,230,000 shares $411.18 million +0.3%N/A5.2 $127.30
9/30/20243,220,000 shares $480.78 million -3.6%N/A5.3 $149.31
9/15/20243,340,000 shares $398.19 million -5.1%N/A5.8 $119.22
8/31/20243,520,000 shares $487.34 million -4.6%N/A8.4 $138.45
8/15/20243,690,000 shares $514.76 million +5.4%N/A10.8 $139.50
7/31/20243,500,000 shares $467.25 million +1.5%N/A10 $133.50
7/15/20243,450,000 shares $472.79 million -2.5%N/A9.4 $137.04
6/30/20243,540,000 shares $482.79 million +2.3%N/A9.6 $136.38
6/15/20243,460,000 shares $441.63 million +1.2%N/A9.2 $127.64
5/31/20243,420,000 shares $462.04 million -1.2%N/A9.3 $135.10
5/15/20243,460,000 shares $429.18 million -6.5%N/A9.3 $124.04
4/30/20243,700,000 shares $512.23 million +2.8%N/A10.9 $138.44
4/15/20243,600,000 shares $522.83 million +7.5%N/A10.3 $145.23
3/31/20243,350,000 shares $506.42 million +14.0%N/A8.9 $151.17
3/15/20242,940,000 shares $437.18 million -2.0%N/A7.5 $148.70
2/29/20243,000,000 shares $443.28 million +1.0%N/A5.7 $147.76
2/15/20242,970,000 shares $437.18 million +1.4%N/A5.2 $147.20
1/31/20242,930,000 shares $380.69 million -9.9%N/A5.2 $129.93
1/15/20243,250,000 shares $426.50 million -4.7%N/A5.8 $131.23
12/31/20233,410,000 shares $429.49 million -17.8%N/A6 $125.95
12/15/20234,150,000 shares $502.03 million -19.7%N/A7.4 $120.97
11/30/20235,170,000 shares $519.22 million +3.6%N/A10.9 $100.43
11/15/20234,990,000 shares $463.92 million -9.8%N/A13.1 $92.97
10/31/20235,530,000 shares $493.88 million +22.9%N/A15.4 $89.31
10/15/20234,500,000 shares $421.07 million +9.8%N/A13.3 $93.57
9/30/20234,100,000 shares $383.92 million +1.0%N/A14.9 $93.64
9/15/20234,060,000 shares $416.80 million -10.6%N/A15.2 $102.66
8/31/20234,540,000 shares $445.01 million -5.0%N/A18 $98.02
8/15/20234,780,000 shares $442.15 million +6.0%N/A20.2 $92.50
7/31/20234,510,000 shares $406.58 million +6.9%N/A15.8 $90.15
7/15/20234,220,000 shares $365.16 million +3.4%N/A8.5 $86.53
6/30/20234,080,000 shares $364.14 million +0.7%N/A7 $89.25
6/15/20234,050,000 shares $374.46 million +3.1%N/A5 $92.46
5/31/20233,930,000 shares $341.79 million -11.3%N/A4.9 $86.97
5/15/20234,430,000 shares $427.89 million +13.6%N/A5.5 $96.59
4/30/20233,900,000 shares $272.84 million -21.2%N/A5 $69.96
4/15/20234,950,000 shares $401.79 million +51.8%N/A9 $81.17
3/31/20233,260,000 shares $349.54 million -0.3%N/A6.2 $107.22
3/15/20233,270,000 shares $354.86 million -0.3%N/A12.6 $108.52
2/28/20233,280,000 shares $364.38 million -1.2%N/A8.9 $111.09
2/15/20233,320,000 shares $371.84 million +5.1%N/A8.7 $112.00
1/31/20233,160,000 shares $392.09 million +1.6%N/A7.2 $124.08
1/15/20233,110,000 shares $357.74 million -61.3%N/A6.4 $115.03
12/30/20228,030,000 shares $980.70 million -1.8%N/A16.5 $122.13
12/15/20228,180,000 shares $973.50 million -14.6%N/A15.9 $119.01
11/30/20229,580,000 shares $1.18 billion -1.8%N/A18.9 $123.06
Trump's New Dollar (Ad)

Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel

Watch the free briefing and see the three steps to prepare today
11/15/20229,760,000 shares $1.08 billion -4.7%N/A21.1 $110.15
10/31/202210,240,000 shares $1.18 billion +12.9%N/A22.2 $115.00
10/15/20229,070,000 shares $973.48 million -3.8%N/A20 $107.33
9/30/20229,430,000 shares $973.74 million +11.2%N/A20.3 $103.26
9/15/20228,480,000 shares $926.78 million +6.4%N/A19.6 $109.29
8/31/20227,970,000 shares $713.87 million +6.3%N/A19.7 $89.57
8/15/20227,500,000 shares $807.45 million +27.8%N/A18 $107.66
7/31/20225,870,000 shares $502.06 million -14.6%N/A12 $85.53
7/15/20226,870,000 shares $586.22 million +5.9%N/A14 $85.33
6/30/20226,490,000 shares $603.31 million +9.4%N/A13 $92.96
6/15/20225,930,000 shares $493.32 million -6.8%N/A10.3 $83.19
5/31/20226,360,000 shares $537.48 million -5.6%N/A10.5 $84.51
5/15/20226,740,000 shares $560.23 million +17.0%N/A11.5 $83.12
4/30/20225,760,000 shares $525.72 million -8.7%N/A12 $91.27
4/15/20226,310,000 shares $712.08 million -0.2%N/A14.5 $112.85
3/31/20226,320,000 shares $741.72 million +38.0%N/A15.5 $117.36
3/15/20224,580,000 shares $501.24 million +20.2%N/A14.8 $109.44
2/28/20223,810,000 shares $428.21 million +9.2%N/A14.6 $112.39
2/15/20223,490,000 shares $427.84 million -3.6%N/A13.7 $122.59
1/31/20223,620,000 shares $440.34 million +27.5%N/A14.6 $121.64
1/15/20222,840,000 shares $349.21 million +4.4%N/A11.2 $122.96
12/31/20212,720,000 shares $365.92 million +4.6%N/A11.6 $134.53
12/15/20212,600,000 shares $348.79 million +1.6%N/A11.6 $134.15
11/30/20212,560,000 shares $350.77 million +5.8%N/A12.5 $137.02
11/15/20212,420,000 shares $370.60 million +2.5%N/A9.5 $153.14
10/29/20212,360,000 shares $357.80 million -3.3%N/A9.4 $151.61
10/15/20212,440,000 shares $390.38 million +1.7%N/A10 $159.99
9/30/20212,400,000 shares $382.54 million -2.4%N/A10.2 $159.39
9/15/20212,460,000 shares $387.01 million -7.9%N/A10.5 $157.32
8/31/20212,670,000 shares $418.47 million -5.7%5.2%11.1 $156.73

ASND Short Interest - Frequently Asked Questions

Short interest is the volume of Ascendis Pharma A/S shares that have been sold short but have not yet been closed out or covered. As of August 14th, traders have sold 3,687,311 shares of ASND short. 9.85% of Ascendis Pharma A/S's shares are currently sold short. Learn More on Ascendis Pharma A/S's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ASND shares currently have a short interest ratio of 6.3. Learn More on Ascendis Pharma A/S's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.85% of Ascendis Pharma A/S's floating shares are currently sold short.

Ascendis Pharma A/S saw a increase in short interest in the month of August. As of August 14th, there was short interest totaling 3,687,311 shares, an increase of 8.3% from the previous total of 3,404,687 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

9.85% of Ascendis Pharma A/S's shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Ascendis Pharma A/S: Moderna, Inc. (14.83%), Natera, Inc. (3.14%), Revolution Medicines, Inc. (4.91%), Biogen Inc. (3.52%), Alnylam Pharmaceuticals, Inc. (3.60%), BioNTech SE Sponsored ADR (1.23%), Insmed, Inc. (5.09%), Roivant Sciences Ltd. (4.65%), Incyte Corporation (5.53%), United Therapeutics Corporation (5.39%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($71.57 billion), Invesco QQQ ($46.97 billion), iShares Russell 2000 ETF ($24.02 billion), Nebius Group N.V. ($15.37 billion), Sandisk Corporation ($12.60 billion), SPDR S&P Biotech ETF ($12.14 billion), Western Digital Corporation ($10.32 billion), iShares 20+ Year Treasury Bond ETF ($8.38 billion), VanEck Semiconductor ETF ($7.62 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($7.07 billion). View all of the most shorted stocks.

Short selling ASND is an investing strategy that aims to generate trading profit from Ascendis Pharma A/S as its price is falling. ASND shares are trading down $1.45 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Ascendis Pharma A/S occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ASND, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ASND, twice per month. The most recent reporting period available is August, 14 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like ASND:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for NASDAQ:ASND is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 8/25/2026. FINRA publishes updated short interest twice a month.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel